Registro:

Referencias:

• Franks, S., Polycystic ovary syndrome (1995) N Engl J Med, 333, pp. 853-861
• Okon, M.A., Laird, S.M., Tuckerman, E.M., Li, T.-C., Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function (1998) Fertility and Sterility, 69 (4), pp. 682-690. , DOI 10.1016/S0015-0282(98)00007-7, PII S0015028298000077
• Tuckerman, E.M., Okon, M.A., Li, T., Laird, S.M., Do androgens have a direct effect on endometrial function? An in vitro study (2000) Fertil Steril, 74, pp. 771-779
• Sir-Petermann, T., Maliqueo, M., Angel, B., Lara, H.E., Perez-Bravo, F., Recabarren, S.E., Maternal serum androgens in pregnant women with polycystic ovarian syndrome: Possible implications in prenatal androgenization (2002) Human Reproduction, 17 (10), pp. 2573-2579
• Balen, A.H., Tan, S.-L., MacDougall, J., Jacobs, H.S., Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin (1993) Human Reproduction, 8 (6), pp. 959-964
• Pillay, O.C., Te Fong, L.F., Crow, J.C., Benjamin, E., Mould, T., Atiomo, W., The association between polycystic ovaries and endometrial cancer (2006) Hum Reprod, 21, pp. 924-929
• Elia, E., Vighi, S., Lombardi, E., Motta, A.B., Detrimental effects of hyperandrogenism on uterine functions (2008) Int Immunopharmacol, 8, pp. 1827-1834
• Elia, E.M., Belgorosky, D., Faut, M., Vighi, S., Pustovrh, C., Devoto, L., The effects of metformin on uterine tissue of hyperandrogenized BALB/c mice (2009) Mol Hum Reprod, 15, pp. 421-432
• Sander, V., Solano, M.E., Elia, E., Luchetti, C.G., Di Girolamo, G., Gonzalez, C., Motta, A.B., The influence of dehydroepiandrosterone on early pregnancy in mice (2005) NeuroImmunoModulation, 12 (5), pp. 285-292. , DOI 10.1159/000087106
• Solano, M.E., Elia, E., Luchetti, C.G., Sander, V., Di Girolamo, G., Gonzalez, C., Motta, A.B., Metformin prevents embryonic resorption induced by hyperandrogenisation with dehydroepiandrosterone in mice (2006) Reproduction, Fertility and Development, 18 (5), pp. 533-544. , DOI 10.1071/RD05099
• Luchetti, C.G., Mikó, E., Szekeres-Bartho, J., Paz, D.A., Motta, A.B., Dehydroepiandrosterone and metformin modulate progesterone induced blocking factor (PIBF), cyclooxygenase 2 (COX2) and cytokines in early pregnant mice (2008) J Steroid Biochem Mol Biol, 111, pp. 200-207
• Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Moller, D.E., Role of AMP-activated protein kinase in mechanism of metformin action (2001) Journal of Clinical Investigation, 108 (8), pp. 1167-1174. , DOI 10.1172/JCI200113505
• Fryer, L.G.D., Parbu-Patel, A., Carling, D., The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways (2002) Journal of Biological Chemistry, 277 (28), pp. 25226-25232. , DOI 10.1074/jbc.M202489200
• Zou, M.H., Kirkpatrick, S.S., Davis, B.J., Nelson, J.S., Wiles, W.G., Schlattner, U., Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo (2004) J Biol Chem, 279, pp. 43940-43951
• Diamanti-Kandarakis, E., Kouli, C., Tsianateli, T., Bergiele, A., Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome (1998) European Journal of Endocrinology, 138 (3), pp. 269-274. , DOI 10.1530/eje.0.1380269
• Glueck, C.J., Fontaine, R.N., Wang, P., Subbiah, M.T.R., Weber, K., Illig, E., Streicher, P., McCullough, P., Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30 (2001) Metabolism: Clinical and Experimental, 50 (7), pp. 856-861. , DOI 10.1053/meta.2001.24192
• Jakubowicz, D.J., Seppala, M., Jakubowicz, S., Rodriguez-Armas, O., Rivas-Santiago, A., Koistinen, H., Koistinen, R., Nestler, J.E., Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome (2001) Journal of Clinical Endocrinology and Metabolism, 86 (3), pp. 1126-1133. , DOI 10.1210/jc.86.3.1126
• La Marca, A., Morgante, G., Palumbo, M., Cianci, A., Petraglia, F., De Leo, V., Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome (2002) Fertility and Sterility, 78 (6), pp. 1234-1239. , DOI 10.1016/S0015-0282(02)04346-7, PII S0015028202043467
• Velazquez, M.E., Acosta, A., Mendoza, S.G., Menstrual cyclicity after metformin therapy in polycystic ovary syndrome (1997) Obstetrics and Gynecology, 90 (3), pp. 392-395. , DOI 10.1016/S0029-7844(97)00296-2, PII S0029784497002962
• Glueck, C.J., Goldenberg, N., Wang, P., Loftspring, M., Sherman, A., Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: Prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy (2004) Human Reproduction, 19 (3), pp. 510-521. , DOI 10.1093/humrep/deh109
• Issemann, I., Green, S., Activation of a member of the steroid hormonal receptor superfamily by peroxisome proliferators (1990) Nature, 347, pp. 645-650
• Needleman, P., Turk, J., Jakschik, B.A., Morrison, A.R., Lefkowith, J.B., Arachidonic acid and metabolism (1986) Annu Rev Biochem, 55, pp. 69-102
• Kuhn, H., Borngraber, S., Mammalian 15-lipoxygenases: Enzymatic properties and biological implications (1999) Advances in Experimental Medicine and Biology, 447, pp. 5-28
• Brash, A.R., Lipoxygenases: Occurrence, functions, catalysis, and acquisition of substrate (1999) J Biol Chem, 274, pp. 23679-23682
• Conrad, D.J., The arachidonate 12/15 lipoxygenases: A review of tissue expression and biologic function (1999) Clinical Reviews in Allergy and Immunology, 17 (1-2), pp. 71-89
• Li, Q., Cheon, Y.-P., Kannan, A., Shanker, S., Bagchi, I.C., Bagchi, M.K., A Novel Pathway Involving Progesterone Receptor, 12/ 15-Lipoxygenase- derived Eicosanoids, and Peroxisome Proliferator-activated Receptor Regulates Implantation in Mice (2004) Journal of Biological Chemistry, 279 (12), pp. 11570-11581. , DOI 10.1074/jbc.M311773200
• Pan, Q.R., Li, W.H., Wang, H., Sun, Q., Xiao, X.H., Brock, B., Glucose, metformin, and AICAR regulate the expression of G protein-coupled receptor members in INS-1 beta cell (2009) Horm Metab Res, 41, pp. 799-804
• Prabhakar, P.K., Doble, M., Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes (2009) Phytomedicine, 16, pp. 1119-1122
• Sung, B., Park, S., Yu, B.P., Chung, H.Y., Amelioration of age-related inflammation and oxidative stress by PPAR activator: Suppression of NF-κB by 2,4-thiazolidinedione (2006) Experimental Gerontology, 41 (6), pp. 590-599. , DOI 10.1016/j.exger.2006.04.005, PII S0531556506001033
• Glueck, C.J., Moreira, A., Goldenberg, N., Sieve, L., Wang, P., Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin (2003) Human Reproduction, 18 (8), pp. 1618-1625. , DOI 10.1093/humrep/deg343
• Legro, R.S., Pregnancy considerations in women with polycystic ovary syndrome (2007) Clinical Obstetrics and Gynecology, 50 (1), pp. 295-304. , DOI 10.1097/GRF.0b013e31803057ed, PII 0000308120070300000026
• Subbaramaiah, K., Lin, D.T., Hart, J.C., Dannenberg, A.J., Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2: Evidence for involvement of activator protein-1 and CREB-binding protein/p300 (2001) J Biol Chem, 276, pp. 12440-12448
• Sander, V.A., Facorro, G.B., Piehl, L., Rubín De Celis, E., Motta, A.B., Effect of dehydroepiandrosterone and metformin on corpus luteum in mice (2009) Reproduction, 138, pp. 571-579
• Huang, J.T., Welch, J.S., Ricote, M., Binder, C.J., Willson, T.M., Kelly, C., Witztum, J.L., Glass, C.K., Interleukin-4-dependent production of PPAR- ligands in macrophages by 12/15-lipoxygenase (1999) Nature, 400 (6742), pp. 378-382. , DOI 10.1038/22572
• Schild, R.L., Schaiff, W.T., Carlson, M.G., Cronbach, E.J., Nelson, D.M., Sadovsky, Y., The activity of PPARin primary human trophoblasts is enhanced by oxidized lipids (2002) Journal of Clinical Endocrinology and Metabolism, 87 (3), pp. 1105-1110. , DOI 10.1210/jc.87.3.1105
• Nagy, L., Tontonoz, P., Alvarez, J.G.A., Chen, H., Evans, R.M., Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR (1998) Cell, 93 (2), pp. 229-240. , DOI 10.1016/S0092-8674(00)81574-3
• Chen, Q., Sun, X., Chen, J., Cheng, L., Wang, J., Wang, Y., Sun, Z., Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulose-lutein cells (2009) Reprod Biol Endocrinol, 7, pp. 147-152
• Cheon, Y.-P., Li, Q., Xu, X., Demayo, F.J., Bagchi, I.C., Bagchi, M.K., A genomic approach to identify novel progesterone receptor regulated pathways in the uterus during implantation (2002) Molecular Endocrinology, 16 (12), pp. 2853-2871. , DOI 10.1210/me.2002-0270

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------